🔎 Trials Near Me

Dachaigh › Syndrome Bronchiolitis Obliterans › Massachusetts

Sgrùdaidhean clionaigeach Syndrome Bronchiolitis Obliterans ann an Massachusetts

Tha 14 sgrùdaidhean airson Syndrome Bronchiolitis Obliterans a’ lorg phàirtichean aig làraichean ann an Massachusetts.

Bailtean ann an Massachusetts

Teacsa sgrùdaidh oifigeil (Beurla)

Axatilimab for Sclerotic Chronic Graft-versus-Host Disease

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT07011810

A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

  • Dana-Farber Cancer Institute- Site Number : 8400007, Boston
A’ fastadhÌre 2
Aoisean 1 gu 18 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07116031

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT05996627

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06585774

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

  • Massachusetts Cancer Research Center, Boston
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05919511

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1
Aoisean 2 agus nas sine · Gach gnè · Air ùrachadh 23 Iuch 2026 · NCT06991361

Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD

  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
A’ fastadhSgrùdadh amharc
Aoisean 7 agus nas sine · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT07434869

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

  • Massachusetts General Hospital, Boston
A’ fastadhÌre 2
Aoisean 2 agus nas sine · Gach gnè · Air ùrachadh 16 Ògmh 2026 · NCT04710576

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

  • Dana-Farber Cancer Institute, Boston
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT05922761

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT06615050

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

  • Joined Bio, Lexington
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT07128966

Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial

  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Màrt 2026 · NCT05236062

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Dùbh 2025 · NCT06619561

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Gibl 2025 · NCT06462365

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.